Bristol-Myers Squibb revenue by segment 2015-2020

Published by
Matej Mikulic,
Feb 15, 2022
Shown is the revenue of biopharma company Bristol-Myers Squibb by brand type from 2015 to 2020. In 2020, BMS' by far larger segment was the Prioritized Brands area, generating over 40 billion U.S. dollars in revenue.

Revenue of Bristol-Myers Squibb by segment from 2015 to 2020 (in million U.S. dollars)

CharacteristicPrioritized BrandsEstablished Brands
2020 40,301 2,217
2019* 23,858 2,287
2018 19,460 3,101
2017 15,779 4,997
2016 12,409 7,018
2015 7,436 9,124
Showing entries 1 to 6 (6 entries in total)
Created with Highcharts 7.2.2Revenue in million U.S. dollars7,4367,43612,40912,40915,77915,77919,46019,46023,85823,85840,30140,3019,1249,1247,0187,0184,9974,9973,1013,1012,2872,2872,2172,217Prioritized BrandsEstablished Brands20152016201720182019*2020
010,00020,00030,00040,00050,000

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

February 2021

Region

Worldwide

Survey time period

2015 to 2020

Supplementary notes

* Some product revenues in 2019 were already impacted by the acquisition of Celgene (Revlimid, e.g.).

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Leading companies trust Statista:
paypal google adobe pg samsung telekom

Related reports: Available to download in PDF or PPTX format

All datain one format
All data
in one format
Pharma and biotech M&A activity
  • 34 page/s
  • English
  • pptx
  • Detailed references

Everything on "Pharma and biotech M&A activity" in one document: edited and divided into chapters, including detailed references.

Go to report
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on " Pharma and biotech M&A activity "

Other statistics that may interest you Pharma and biotech M&A activity

Industry overview

5

Number of deals

7

Value of deals

5

2021 outlook

4

Mega-merger: BMS/Celgene

5

Discover Statista

Need help with using Statista for your research? Tutorials and first steps

Further Content: You might find this interesting as well

Topics

Pharmaceutical and biotech M&A activitiesGlobal pharmaceutical industryM&As worldwideM&As in EuropeM&As in the United States
Do you have any questions about our business solutions?

We provide you with detailed information about our Professional Account.

All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.